Literature DB >> 33019818

Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 Years.

Stephan Vlaminck1, Frederic Acke2, Emmanuel Prokopakis3, Kato Speleman1, Hideyuki Kawauchi4, Jean-Christophe van Cutsem1, Peter W Hellings5, Mark Jorissen5, Sven Seys5, Claus Bachert2, Thibaut Van Zele2, Bart N Lambrecht6,7,8, Philippe Gevaert2.   

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) often requires surgery, but recurrence even after surgery is common. Recurrence rates largely vary in literature and asthma seems to be a comorbid factor.
OBJECTIVE: In this study, we aim to estimate disease recurrence during a long-term follow-up, together with the investigation of possible predicting and/or influencing parameters.
METHODS: Out of 196 patients operated for CRSwNP between 01/2000 and 01/2006, 133 patients had a follow-up of at least 10 years and could be included. The inflammatory profile at surgery was determined on nasal tissue and sinonasal secretions, and included analysis of eosinophils, eosinophilic-rich mucus (ERM) typically containing Charcot-Leyden crystals (CLC), and fungal hyphae (FH). During follow-up, recurrence, received treatments and comorbidities were collected.
RESULTS: Out of the 133 included patients, local eosinophilia was present in 81% and ERM in 60%. Recurrence during follow-up was observed in 62%, and was associated with local eosinophilia and ERM (both p < 0.001). Asthma was present in 28% at inclusion, and 17% developed asthma after surgery during follow-up. The presence of asthma, at inclusion as well as developed during follow-up, was significantly associated with recurrence of CRSwNP (p = 0.001 for group comparison).
CONCLUSION: Recurrence after CRSwNP surgery is common when a long-term follow-up is taken into account. ERM detected in sinonasal secretions at surgery seems to be a predictive factor for recurrence and need for revision surgery. Asthma is a frequently found comorbid factor in CRSwNP, develops even at higher age despite surgical treatment for CRSwNP, and is also associated with a higher recurrence rate. Sustained medical care after surgery is mandatory.

Entities:  

Keywords:  CRSwNP; SNOT-22; adult onset asthma; asthma; chronic rhinosinusitis; endoscopic sinus surgery; eosinophilic-rich mucus; follow-up; nasal polyps; outcome

Year:  2020        PMID: 33019818     DOI: 10.1177/1945892420961964

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  5 in total

1.  Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps.

Authors:  Junqin Bai; Julia H Huang; Caroline P E Price; Jacob M Schauer; Lydia A Suh; Regan Harmon; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Anju T Peters; Whitney W Stevens; Atsushi Kato; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2022-03-16       Impact factor: 14.290

2.  Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment.

Authors:  Eugenio De Corso; Stefano Settimi; Claudio Montuori; Marco Corbò; Giulio Cesare Passali; Davide Paolo Porru; Simone Lo Verde; Camilla Spanu; Daniele Penazzi; Giuseppe Alberto Di Bella; Eleonora Nucera; Matteo Bonini; Gaetano Paludetti; Jacopo Galli
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

Review 3.  Rethinking neutrophils and eosinophils in chronic rhinosinusitis.

Authors:  Tim Delemarre; Bruce S Bochner; Hans-Uwe Simon; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2021-04-21       Impact factor: 14.290

Review 4.  Pathophysiological and Clinical Aspects of Chronic Rhinosinusitis: Current Concepts.

Authors:  Stephan Vlaminck; Frederic Acke; Glenis K Scadding; Bart N Lambrecht; Philippe Gevaert
Journal:  Front Allergy       Date:  2021-10-27

Review 5.  Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology.

Authors:  Eugenio De Corso; Gianluca Bellocchi; Michele De Benedetto; Nicola Lombardo; Alberto Macchi; Luca Malvezzi; Gaetano Motta; Fabio Pagella; Claudio Vicini; Desiderio Passali
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-07-23       Impact factor: 2.618

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.